Page 4 - Probe Development News Today

Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced it entered a 15-year lease agreement with Hamilton, Ontario-based McMaster University to build a 27,000 square foot current Good Manufacturing Practice (GMP) compliant radiopharmaceutical manufacturing facility. The facility, to be built by McMaster and equipped and validated by Fusion, will be designed to support manufac

CPDC Announces Appointment of Bruno Paquin as Permanent CEO News provided by Share this article Share this article HAMILTON, ON, March 10, 2021 /PRNewswire/ - The Centre for Probe Development and Commercialization (CPDC) announced that its Board of Directors has appointed Bruno Paquin as Chief Executive Officer (CEO). The CEO appointment has taken effect on March 4, 2021.  Dr. John Thornback, Chair of the Board of Directors said, "W e are pleased to announce that Bruno Paquin has been appoin...

Published: Feb 24, 2021   HAMILTON, ON, Feb. 24, 2021 /PRNewswire/ - The Centre for Probe Development and Commercialization (CPDC), a global leader in the development, production and commercialization of radiopharmaceuticals, is announcing today that the first patient has been dosed and imaged in a Phase 3 trial for [ 18F]PSMA-1007. This diagnostic imaging product is a positron-emitting tomography (PET) agent that targets Prostate Specific Membrane Antigen (PSMA), a protein that is overex...

/PRNewswire/ - The Centre for Probe Development and Commercialization (CPDC), a global leader in the development, production and commercialization of...

4 Min Read MONTREAL/TORONTO (Reuters) - Medical companies and shippers in Canada are racing to transport time-sensitive radiochemical materials used to treat cancer, as a pandemic-induced drop in passenger flights has narrowed transportation options and created cargo delays. FILE PHOTO: An American Airlines cargo plane is unloaded at Philadelphia International Airport in Philadelphia, Pennsylvania, U.S., December 4, 2020. REUTERS/Rachel Wisniewski/File Photo Half of air cargo normally travels i...

(1) TORONTO, Jan. 12, 2021 (GLOBE NEWSWIRE) -- POINT Biopharma Inc. (POINT), a radiopharmaceutical company dedicated to bringing the many benefits of precision radioligand therapy to cancer patients, today announced that it has signed a licensing and commercialization agreement with CanProbe for exclusive rights to Lutetium - 177 Octreotate (Lu-DOTATATE) for the treatment of neuroendocrine cancer. CanProbe, a joint venture between the University Health Network (UHN) and the Centre for Probe D...

POINT Biopharma POINT Biopharma Signs Exclusive License Agreement with CanProbe for the Commercialization of a Neuroendocrine Tumor Treatment POINT Biopharma Signs Exclusive License Agreement with CanProbe for the Commercialization of a Neuroendocrine Tumor Treatment TORONTO, Jan. 12, 2021 (GLOBE NEWSWIRE) -- POINT Biopharma Inc. (POINT), a radiopharmaceutical company dedicated to bringing the many benefits of precision radioligand therapy to cancer patients, today announced that it has signe...

MONTREAL/TORONTO (REUTERS) - Medical companies and shippers in Canada are racing to transport time-sensitive radiochemical materials used to treat cancer, as a pandemic-induced drop in passenger flights has narrowed transportation options and created cargo delays. Half of air cargo normally travels in the belly of passenger jets rather than dedicated freighters. But flight cancellations as traffic plummeted during the pandemic have left some companies scrambling to ship treatments that decay ov...

Medical companies and shippers in Canada are racing to transport time-sensitive radiochemical materials used to treat cancer, as a pandemic-induced drop in passenger flights has narrowed transportation options and created cargo delays.

  MONTREAL/TORONTO -- Medical companies and shippers in Canada are racing to transport time-sensitive radiochemical materials used to treat cancer, as a pandemic-induced drop in passenger flights has narrowed transportation options and created cargo delays. Half of air cargo normally travels in the belly of passenger jets rather than dedicated freighters. But flight cancellations as traffic plummeted during the pandemic have left some companies scrambling to ship treatments that decay over ...